Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Gelsi-Boyer V, Trouplin V, Adelaide J, Bonansea J, Cervera N, Carbuccia N et al. Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Br J Haematol 2009; 145: 788–800.

    Article  CAS  Google Scholar 

  2. Fisher CL, Randazzo F, Humphries RK, Brock HW . Characterization of Asxl1, a murine homolog of Additional sex combs, and analysis of the Asx-like gene family. Gene 2006; 369: 109–118.

    Article  CAS  Google Scholar 

  3. Carbuccia N, Murati A, Trouplin V, Brecqueville M, Adelaide J, Rey J et al. Mutations of ASXL1 gene in myeloproliferative neoplasms. Leukemia 2009; 23: 2183–2186.

    Article  CAS  Google Scholar 

  4. Carbuccia N, Trouplin V, Gelsi-Boyer V, Murati A, Rocquain J, Adelaide J et al. Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias. Leukemia 2009. E-pub ahead of print 29 October 2009; doi:2010.103/leu.2009.2218.

  5. Cho YS, Kim EJ, Park UH, Sin HS, Um SJ . Additional sex comb-like 1 (ASXL1), in cooperation with SRC-1, acts as a ligand-dependent coactivator for retinoic acid receptor. J Biol Chem 2006; 281: 17588–17598.

    Article  CAS  Google Scholar 

  6. Wang L, Fidler C, Nadig N, Giagounidis A, Della Porta MG, Malcovati L et al. Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays. Haematologica 2008; 93: 994–1000.

    Article  Google Scholar 

  7. Bench AJ, Nacheva EP, Hood TL, Holden JL, French L, Swanton S et al. Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. UK Cancer Cytogenetics Group (UKCCG). Oncogene 2000; 19: 3902–3913.

    Article  CAS  Google Scholar 

  8. Pellagatti A, Cazzola M, Giagounidis AA, Malcovati L, Porta MG, Killick S et al. Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype. Blood 2006; 108: 337–345.

    Article  CAS  Google Scholar 

  9. Lee SW, Cho YS, Na JM, Park UH, Kang M, Kim EJ et al. ASXL1 represses retinoic acid receptor-mediated transcription through associating with HP1 and LSD1. J Biol Chem 2010; 285: 18–29.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by Leukaemia Research of the United Kingdom, and in part by grants from AIRC (Associazione Italiana per la Ricerca sul Cancro) and Fondazione IRCCS Policlinico San Matteo to MC, and by a grant from CajaNavarra Foundation through the Program ‘You choose, you decide’ (Project 10.830) to MFM. We are grateful to the clinicians who have contributed to the clinical assessment of the patients: Dr J Rifón (University Clinic, University of Navarra, Spain), Dr T Carrascosa (Galdakano Hospital, Spain), Dr G Hermida (General Yagüe Hospital, Spain), Dr JJ Hernández-Hernández (San Eloy Hospital, Spain), Dr M Rodríguez-Calvillo (San Miguel Hospital, Spain), Dr A Pereda Vicandi (Santiago Hospital, Spain), Dr MT Ardanaz (Txagorritxu Hospital, Spain), Dr J Feliú (San Millán Hospital, Spain), Dr MC Mateos (Virgen del Camino Hospital, Spain), Dr M Araiz (Nuestra Señora de Aranzazu Hospital, Spain), Dr MA Piñán (Cruces Hospital, Spain) and Dr A Gorosquieta (Hospital of Navarra, Spain).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J Boultwood.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boultwood, J., Perry, J., Pellagatti, A. et al. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia. Leukemia 24, 1062–1065 (2010). https://doi.org/10.1038/leu.2010.20

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2010.20

This article is cited by

Search

Quick links